Frequent Mutation of the PI3K Pathway in Head and Neck Cancer Defines Predictive BiomarkersVivian Wai Yan Lui, Jennifer R. Grandis, Brenda Diergaarde et al.|Cancer Discovery|2013Cited by 590
Human Papillomavirus Regulates HER3 Expression in Head and Neck Cancer: Implications for Targeted HER3 Therapy in HPV+ PatientsToni M. Brand, Jennifer R. Grandis, Stefan Hartmann et al.|Clinical Cancer Research|2016Cited by 58
Use of nonsteroidal anti-inflammatory drugs predicts improved patient survival for <i>PIK3CA</i>-altered head and neck cancerMatthew L. Hedberg, Jennifer R. Grandis, Noah D. Peyser et al.|The Journal of Experimental Medicine|2019Cited by 57
Genomic Correlate of Exceptional Erlotinib Response in Head and Neck Squamous Cell CarcinomaEliezer M. Van Allen, Jennifer R. Grandis, Vivian Wai Yan Lui et al.|JAMA Oncology|2015Cited by 47
Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck CancerToni M. Brand, Jennifer R. Grandis, Stefan Hartmann et al.|Cancer Research|2018Cited by 43